Polymorphism of the vitamin D receptor gene and corticosteroid-related osteoporosis

Osteoporosis International

Volumn 9, Issue 2, 1999, Pages 134-138

  Ho, Y V ^a   Briganti, E M ^a   Duan, Y ^a   Buchanan, R ^a   Hall, S ^b   Seeman, Ego ^a,c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b CABRINI INSTITUTE   (Australia)

^c AUSTIN HEALTH   (Australia)

Author keywords

Bone mineral density; Corticosteroids; Osteoporosis; Vitamin D receptor gene

Indexed keywords

CORTICOSTEROID; PREDNISOLONE; VITAMIN D RECEPTOR;

ADULT; AGE; AGED; ARTICLE; BODY MASS; BONE ATROPHY; BONE DENSITY; BONE MINERAL; CALCIUM ABSORPTION; CALCIUM INTAKE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE DURATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FRACTURE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INTESTINE ABSORPTION; MAJOR CLINICAL STUDY; MALE; OBSTRUCTIVE AIRWAY DISEASE; ONSET AGE; OSTEOPOROSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SEX DIFFERENCE; SMOKING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, RHEUMATOID; BONE DENSITY; CROSS-SECTIONAL STUDIES; FEMALE; FEMUR; HUMANS; LONGITUDINAL STUDIES; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; OSTEOPOROSIS; POLYMORPHISM, GENETIC; PREDNISONE; RECEPTORS, CALCITRIOL; SPINE;

EID: 0032951678     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001980050126     Document Type: Article

References (23)

1. Sambrook PN, Kelly PJ, Keogh A, et al. Bone loss after cardiac-transplantation: a prospective study. J Heart Lung Transpl 1994;13:116-21.
2. Reid IR, Heap SW. Determinants of vertebral mineral density in patients receiving long-term glucocorticoid therapy. Arch Intern Med 1990;150:2545-8.
3. Peel NF, Moore DJ, Barrington NA, Bax DE, Eastell R. Risk of vertebral fracture and the relationship to bone mineral density in steroid treated rheumatoid arthritis. Ann Rheum Dis 1995;54:801-6.
4. Formiga F, Moga I, Nolla JM, Pac M, Mitjavila F, Roig-Escofet D. Loss of bone mineral density in premenopausal women with systemic lupus erythematosus. Ann Rheum Dis 1995;54:274-6.
5. Lukert BP, Raisz LG. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 1990;112:352-64.
6. Hanania NA, Chapman KR, Sturtridge WC, Szalai JP, Kesten S. Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids. J Allergy Clin Immunol 1995;96:571-9.
7. Morrison NA, Qi JC, Tokita A, et al. Prediction of bone density from vitamin D receptor alleles. Nature 1994;367:284-7.
8. Spector TD, Keen RW, Arden NK, et al. Influence of vitamin D receptor genotypes on bone mineral density in postmenopausal women: a twin study in Britain. BMJ 1995;310:1357-60.
9. Sainz J, Van Tornout JM, Loro ML, Sayre J, Roe TF, Gilsanz V. Vitamin D receptor gene polymorphisms and bone density in prepubertal American girls of Mexican descent. N Engl J Med 1997;337:77-82.
10. Riggs BL, Nguyen TV, Melton LJ, et al. The contribution of vitamin D receptor gene alleles to the determination of bone mineral density in normal and osteoporotic women. J Bone Miner Res 1995;10:991-6.
11. Fleet JC, Harris SS, Wood RJ, Dawson-Hughes B. The BsmI vitamin D receptor restriction fragment length polymorphism (BB) predicts low bone density in premenopausal black and white women. J Bone Miner Res 1995;10:985-90.
12. Krall EA, Parry P, Lichter JB, Dawson-Hughes B. Vitamin D receptor alleles and rates of bone loss: influence of years since menopause and calcium intake. J Bone Miner Res 1995;10:978-84.
13. Yamagata Z, Miyamura T, Iijima S, et al. Vitamin D receptor gene polymorphism and bone mineral density in healthy Japanese women. Lancet 1994;344:1027.
14. Dawson-Hughes B, Harris SS, Finneran S. Calcium absorption on high and low calcium intakes in relation to vitamin D receptor genotype. J Clin Endocrinol Metab 1995;80:3657-61.
15. Ferrari S, Bonjour JP. Genetics-dietary calcium interaction and bone mass. In: Heaney R, Burkhardt P, editors. Nutritional and bone Serono symposium series. Lausanne: Serono Symposic, 1998 (in press).
16. Hustmyer FG, Peacock M, Hui S, Johnston CC, Christian J. Bone mineral density in relation to polymorphism at the vitamin D receptor gene locus. J Clin Invest 1994;94:2130-4.
17. Garnero P, Borel O, Sornay-Rendu E, Delmas PD. Vitamin D receptor gene polymorphisms do not predict bone turnover and bone mass in healthy premenopausal women. J Bone Miner Res 1995;10:1283-8.
18. Melhus H, Kindmark A, Amer S, Wilen B, Lindh E, Ljunghal S. Vitamin D receptor genotypes in osteoporosis. Lancet 1994;344:949-50.
19. Spotila LD, Caminis J, Johnson R, et al. Vitamin D receptor genotype is not associated with bone mineral density in three ethnic/regional groups. Calcif Tissue Int 1996;59:235-7.
20. Francis RM, Harrington F, Turnere E, Papiha SS, Datta HK. Vitamin D receptor gene polymorphism in men and its effect on bone density and calcium absorption. Clin Endocrinol 1997;46:83-6.
21. Torres A, Machado M, Concepcion MT, et al. Influence of vitamin D receptor genotype on bone mass changes after renal transplantation. Kidney Int 1996;50:1726-33.
22. Houston LA, Grant SF, Reid DM, Ralston SH. Vitamin D receptor polymorphism, bone mineral desnity, and osteoporotic vertebral fractures: studies in a UK population. Bone 1996;18:249-52.
23. Uitterlinden AG, Pols HA, Burger H, et al. A large scale population based study of the association of vitamin D receptor gene polymorphisms with bone mineral density. J Bone Miner Res 1996;11:1241-8.